Jason "Norm" Shore

Jason "Norm" Shore has a diverse work experience spanning multiple companies and roles. Jason "Norm" began their career at Unilever in 1993, where they served as a Commercial Director until 2000. From 2000 to 2002, they co-founded and served as the CFO of SBX Management, Inc. Following this, they joined Pharmedica Holdings, LLC, where they held various positions including COO, CFO, and Co-CEO from 2002 to 2006. Shore then joined Yankee Group in 2006, where they served as the COO, CFO, and Acting CEO until 2012. Jason "Norm" next joined True Office as the CFO from 2012 to 2014, which was later acquired by Intercontinental Exchange. At Intercontinental Exchange, Shore served as the Director of Sales and Business Development, NYSE Governance Services from 2014 to 2017. Currently, Shore is the CEO of Patient Discovery, a position they have held since 2017.

Jason "Norm" Shore completed their Bachelor of Arts (B.A.) degree in History at Colgate University from 1984 to 1988. Jason "Norm" then pursued further education at the University of Michigan - Stephen M. Ross School of Business, where they earned their Master of Business Administration (MBA) degree with a specialization in Finance from 1991 to 1993.